2018, Number S1
<< Back Next >>
Rev Mex Anest 2018; 41 (S1)
Use and considerations of amines in pediatrics
Morán-Alvarado AG, López-Paz CA
Language: Spanish
References: 7
Page: 179-180
PDF size: 149.16 Kb.
Text Extraction
No abstract.
REFERENCES
Rizza A, Bignami E, Belletti A, Polito A, Ricci Z, Isgrò G, et al. Vasoactive drugs and hemodynamic monitoring in pediatric cardiac intensive care: an Italian survey. World J Pediatr Congenit Heart Surg. 2016;7:25-31.
Holmes CL. Vasoactive drugs in the intensive care unit. Curr Opin Crit Care. 2005;11:413-417.
Colleti J Jr, Brunow de Carvalho W. Vasoactive drugs in pediatric shock: in search of a paradigm. Pediatr Crit Care Med. 2017;18:202-203.
Ventura AM, Shieh HH, Bousso A, Góes PF, de Cássia F O Fernandes I, de Souza DC, et al. Double-blind prospective randomized controlled trial of dopamine versus epinephrine as first-line vasoactive drugs in pediatric septic shock. Crit Care Med. 2015;43:2292-2302.
Gist KM, Mizuno T, Goldstein SL, Vinks A. Retrospective evaluation of milrinone pharmacokinetics in children with kidney injury. Ther Drug Monit. 2015;37:792-796.
Marik PE. Low-dose dopamine: a systematic review. Intensive Care Med. 2002;28:877-883.
Angadi U, Westrope C, Chowdhry MF. Is levosimendan effective in paediatric heart failure and post-cardiac surgeries? Interact Cardiovasc Thorac Surg. 2013;17:710-714.
Full text